Insider Transactions in Q3 2022 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2022
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
3,000
-0.91%
|
$285,000
$95.21 P/Share
|
|
Aug 12
2022
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
4,000
-1.19%
|
$376,000
$94.75 P/Share
|
|
Aug 11
2022
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-6.37%
|
$285,000
$95.62 P/Share
|
|
Aug 09
2022
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
51,216
-26.25%
|
$4,916,736
$96.13 P/Share
|
|
Aug 09
2022
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,526
+31.62%
|
$3,184,242
$67.81 P/Share
|
|
Aug 08
2022
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
6,205
-12.83%
|
$595,680
$96.56 P/Share
|
|
Aug 05
2022
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,500
-10.23%
|
$329,000
$94.5 P/Share
|
|
Aug 05
2022
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+9.28%
|
$234,500
$67.81 P/Share
|
|
Jul 08
2022
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,337
-19.28%
|
$652,993
$89.5 P/Share
|
|
Jul 08
2022
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,398
-11.15%
|
$665,820
$90.0 P/Share
|